Skip to main content
. 2021 May 27;2021:5515467. doi: 10.1155/2021/5515467

Table 2.

Clinical symptoms of the patients before and after intervention.

Before intervention After intervention
Variables Intervention (N: 188) Control (N: 208) P value Intervention (N: 188) Control (N: 208) P value
Otalgia 94 (50%) 106 (51%) >0.05 28 (15%) 59 (28%) <0.01
Fever 170 (90%) 172 (83%) <0.01 35 (19%) 92 (44%) <0.01
Irritability 86 (46%) 86 (41%) >0.05 19 (10%) 40 (19%) <0.05
Vomiting 6 (3%) 9 (4%) >0.05 9 (5%) 4 (2%) >0.05
Diarrhea 10 (5%) 8 (4%) >0.05 13 (7%) 5 (2%) <0.05
Coryza 107 (57%) 118 (57%) >0.05 6 (3%) 10 (5%) >0.05
Cough 92 (49%) 106 (51%) >0.05 4 (2%) 10 (5%) >0.05
Pharyngitis 4 (2%) 1 (0.5%) >0.05 0 (0%) 0 (0%)
Nasal congestion 15 (8%) 10 (5%) >0.05 1 (0.5%) 0 (0%) >0.05
Skin rash 21 (11%) 25 (12%) >0.05 2 (1%) 0 (0%) >0.05
Asthma 7 (4%) 10 (5%) >0.05 0 (0%) 0 (0%)
Poor feeding 4 (2%) 1 (0.5%) >0.05 0 (0%) 0 (0%)
Ear drum perforation x x 2 (1%) 1 (0.5%) >0.05
Unilateral erythema of TM 104 (55%) 129 (62%) >0.05 ∗∗ ∗∗
Bilateral erythema of TM 83 (44%) 78 (37%) >0.05 ∗∗ ∗∗
Unilateral MEE 93 (49%) 111 (53%) >0.05 ∗∗ ∗∗
Bilateral MEE 55 (29%) 59 (28%) >0.05 ∗∗ ∗∗

MEE: middle ear effusion; TM: tympanic membrane. Statistically significant. ∗∗Not assessed after 3 days. X: ear drum perforation cases were excluded at initiation of the study.